GeneDx Holdings (WGSWW) Debt to Equity (2020 - 2026)

GeneDx Holdings has disclosed Debt to Equity across 7 years of filings, most recently posting $0.38 for Q1 2026.

• In Q1 2026, Debt to Equity rose 89.17% year-over-year to $0.38; the TTM figure through Mar 2026 stood at $0.38 (up 89.17% YoY), while the FY2025 annual figure was $0.16, down 26.15% from the prior year.
• Debt to Equity climbed to $0.38 in Q1 2026, from $0.16 in the prior quarter.
• Over the last five years, Debt to Equity for WGSWW reached as high as $0.38 in Q1 2026 and fell as low as $0.02 in Q2 2022.
• The 5-year median for Debt to Equity is $0.18 (2025), against an average of $0.15.
• Annual changes were most pronounced in 2024 — Debt to Equity soared 1173.55% — and 2025, when it tumbled 30.64%.
• A 5-year view of Debt to Equity shows it stood at $0.04 in 2022, then surged by 495.59% to $0.23 in 2023, then dropped by 8.39% to $0.21 in 2024, then declined by 26.15% to $0.16 in 2025, then jumped by 143.5% to $0.38 in 2026.
• According to Business Quant data, Debt to Equity over the past three periods registered $0.38, $0.16, and $0.18 for Q1 2026, Q4 2025, and Q3 2025 respectively.